| pubmed-article:16127281 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16127281 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16127281 | lifeskim:mentions | umls-concept:C0015392 | lld:lifeskim |
| pubmed-article:16127281 | lifeskim:mentions | umls-concept:C1708335 | lld:lifeskim |
| pubmed-article:16127281 | lifeskim:mentions | umls-concept:C0068897 | lld:lifeskim |
| pubmed-article:16127281 | lifeskim:mentions | umls-concept:C0439830 | lld:lifeskim |
| pubmed-article:16127281 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:16127281 | pubmed:dateCreated | 2005-9-16 | lld:pubmed |
| pubmed-article:16127281 | pubmed:abstractText | Saccadic eye velocity (SEV) has been shown to be a reliable neurophysiological tool for the assessment of gamma-aminobutyric acid GABA(A) receptor sensitivity. Administration of benzodiazepines targeting the GABA(A) receptor decreases SEV in healthy volunteers. Tiagabine is a new antiepileptic drug which acts via selective blockade of GABA reuptake. Therefore, we examined the effects of tiagabine on saccade parameters. | lld:pubmed |
| pubmed-article:16127281 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16127281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16127281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16127281 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16127281 | pubmed:issn | 0302-282X | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:RupprechtRain... | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:BaghaiThomas... | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:ZwanzgerPeter... | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:PadbergFrankF | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:EllaRobinR | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:SchuleCorneli... | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:EserDanielaD | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:KathmannNorbe... | lld:pubmed |
| pubmed-article:16127281 | pubmed:author | pubmed-author:MollerHans-Jü... | lld:pubmed |
| pubmed-article:16127281 | pubmed:copyrightInfo | Copyright (c) 2005 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:16127281 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16127281 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:16127281 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16127281 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16127281 | pubmed:pagination | 147-50 | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:meshHeading | pubmed-meshheading:16127281... | lld:pubmed |
| pubmed-article:16127281 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16127281 | pubmed:articleTitle | Saccadic eye velocity after selective GABAergic treatment with tiagabine in healthy volunteers. | lld:pubmed |
| pubmed-article:16127281 | pubmed:affiliation | Department of Psychiatry, University of Munich, Nussbaumstrasse 7, DE-80336 Munich, Germany. zwanzger@med.uni-muenchen.de | lld:pubmed |
| pubmed-article:16127281 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16127281 | pubmed:publicationType | Clinical Trial | lld:pubmed |
